Skip to content
Posttest - Tumor Board Tuesday - June, 1, 2021 (ID: i788-11)
*
1.
Please list your last name and zip code:
(Required.)
Last name:
ZIP/Postal Code:
*
2.
What is your specialty?
(Required.)
*
3.
How many patients with pancreatic cancer do you treat each week?
(Required.)
1 to 10
11 to 25
26 to 50
I am not directly involved in patient care
*
4.
What are the recommended genetic tests in mPDAC?
(Required.)
Germline testing
Somatic gene profiling
Both
Neither
*
5.
What biomarker and immune checkpoint inhibitors combinations are appropriate for relapsed mPDAC?
(Required.)
Nivolumab for PD-L1 positive (≥1%)
Pembrolizumab for TMB ≥10
Ipilimumab and Nivolumab for MSI-High PDAC
All of the above